Benjamin Miron, MD
Chemotherapy, targeted therapy, immunotherapy, hormone therapy, clinical trials for genitourinary malignancies
I am a medical oncologist and researcher specializing in the treatment of genitourinary cancers. I became an oncologist after seeing, first hand, how impactful a caring and thoughtful physician can be for patients and their families when dealing with a cancer diagnosis. The field of oncology is rapidly evolving and my mission is to deliver the most cutting-edge, compassionate and personalized care to each and every patient. I am passionate about partnering with my patients to help them understand their disease and give them the information they need to make the best decision for them as individuals taking into account their beliefs, wishes and goals.
I am also a scientist and the fundamental goal of my research is to improve treatment paradigms for patients with genitourinary malignancies by investigating new strategies and technologies to individualize therapy for patients to maximize benefit to them and minimize toxicity. We hope to achieve this by investigating markers that may predict a response to therapy that could be useful for selecting treatment in the future. As more drugs are being developed for genitourinary cancers it will become more important to know apriori which could be of most benefit to our patients to help us personalize their treatments. I also focus on developing and implementing tools to monitor cancers more effectively using novel technologies to detect microscopic amounts of cancer in the blood. These monitoring techniques can help us understand which patients needs to change treatment, intensify therapy or may be able to take a break from treatment all together. Collectively the goal of my research is to will hopefully help us deliver the right treatment to the right patient at the right time to help patients live longer and live better.